As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...
Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research. | Amid a dramatic reshaping of the federal ...
Kennedy Jr., warned in an interview published Friday that Kennedy’s tenure at the HHS has been “very scary” so far. Marks ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the ...
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
2don MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
The head of the US Food and Drug Administration department responsible for assuring the safety and effectiveness of vaccines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results